Phase 2 Lung Transplant Clinical Trials

6 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–6 of 6 trials

Recruiting

Phase 2

Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients

Lung Transplant

National Institute of Allergy and Infectious Diseases (NIAID)234 enrolled12 locationsNCT06476132

Recruiting

Phase 2

Tocilizumab in Lung Transplantation

Lung Transplant

National Institute of Allergy and Infectious Diseases (NIAID)350 enrolled21 locationsNCT06033196

Recruiting

Phase 2

Developing Hyperpolarized Gas MRI Signatures to Detect and Manage Acute Cellular Rejection

Lung Transplant Rejection

University of Virginia60 enrolled1 locationNCT07046910

Recruiting

Phase 2

CMV Immunity Monitoring in Lung Transplant Recipients

Lung Transplant; Complications

NYU Langone Health50 enrolled1 locationNCT05708755

Recruiting

Phase 2

Phase 2 Randomised controlled trial of bone-marrow derived mesenchymal stromal cells (MSC) for new onset chronic lung allograft dysfunction (CLAD)

Lung transplant patients with Chronic Lung Allograph Dysfunction (CLAD)

University of Queensland82 enrolled5 locationsACTRN12616000338460

Completed

Phase 2

A pilot randomised controlled trial of omega-3 fatty acid supplements to prevent skin cancer in lung transplant recipients

Skin CancerLung Transplant

QIMR Berghofer Medical Research Institute100 enrolled1 locationACTRN12614000873628